intralesional umbilical-cord mesenchymal stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for intralesional umbilical-cord mesenchymal stem cells, covering 2023-06-07 to 2023-06-07. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial [Phase 4]